BNP Paribas Asset Management
NAMS icon

BNP Paribas Asset Management’s NewAmsterdam Pharma NAMS Stock Holding History

BNP Paribas Asset Management’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.5M Sell
781,140
-176,302
-18% -$5.81M 0.03% 516
2026
Q1 		$30.6M Buy
957,442
+780,426
+441% +$25.4M 0.04% 452
2025
Q4 		$6.21M Buy
+177,016
New +$6.44M 0.01% 784

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

BNP Paribas Asset Management's NAMS Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its NewAmsterdam Pharma (NAMS) stake by 18% in Q2 2026, selling an estimated $5.81M and leaving 781,140 shares worth $26.5M. The position accounts for 0.03% of the portfolio, ranked #516.

BNP Paribas Asset Management first reported a position in NAMS in Q4 2025 and has held it in 3 quarters since. The position peaked at $30.6M in Q1 2026. 195 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • BNP Paribas Asset Management held 781,140 shares of NewAmsterdam Pharma worth $26.5M as of Q2 2026.
  • BNP Paribas Asset Management sold 176,302 NewAmsterdam Pharma shares in Q2 2026, an estimated $5.81M.
  • NewAmsterdam Pharma made up 0.03% of BNP Paribas Asset Management's portfolio in Q2 2026, its #516 holding.
  • BNP Paribas Asset Management first reported a position in NewAmsterdam Pharma in Q4 2025 and has held it in 3 quarters since.
  • BNP Paribas Asset Management's NewAmsterdam Pharma position peaked at $30.6M in Q1 2026.
  • 195 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.